Загрузка...
Timing of dornase alfa inhalation for cystic fibrosis
BACKGROUND: Inhalation of the enzyme dornase alfa reduces sputum viscosity and improves clinical outcomes of people with cystic fibrosis. This is an update of a previously published Cochrane review. OBJECTIVES: To determine the effect of timing of dornase alfa inhalation on measures of clinical effi...
Сохранить в:
| Опубликовано в: : | Cochrane Database Syst Rev |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Ltd
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6474180/ https://ncbi.nlm.nih.gov/pubmed/27457496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007923.pub4 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|